Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (421-430 of 655) with videos related to

Pageof 66
Sort By:
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma GroupW P Steward, H T Mouridsen, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials GroupJ Verweij, J Wanders, A L Nielsen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksL J van Warmerdam, J Verweij, J H Schellens, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Renal function as a predictor of irinotecan-induced neutropeniaF A de Jong, J M van der Bol, R H J Mathijssen, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Post-travel screening of asymptomatic long-term travelers to the tropics for intestinal parasites using molecular diagnosticsDarius Soonawala, Lisette van Lieshout, Marion A M den Boer, et al.
British Journal of Cancer|February 22, 2002
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancerM E L van der Burg, R de Wit, W L J van Putten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Paclitaxel (Taxol) induces cumulative mild neurotoxicityJ M van Gerven, J W Moll, M J van den Bent, et al.
Japanese Journal of Infectious Diseases|October 25, 2006
Intestinal microsporidiosis in diarrheal patients infected with human immunodeficiency virus-1 in Addis Ababa, EthiopiaTekola Endeshaw, Amha Kebede, Jaco J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.
Pageof 66

Showing results (421-430 of 655) with videos related to

Sort By:
Pageof 66
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma GroupW P Steward, H T Mouridsen, P Kerbrat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials GroupJ Verweij, J Wanders, A L Nielsen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeksL J van Warmerdam, J Verweij, J H Schellens, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Renal function as a predictor of irinotecan-induced neutropeniaF A de Jong, J M van der Bol, R H J Mathijssen, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Post-travel screening of asymptomatic long-term travelers to the tropics for intestinal parasites using molecular diagnosticsDarius Soonawala, Lisette van Lieshout, Marion A M den Boer, et al.
British Journal of Cancer|February 22, 2002
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancerM E L van der Burg, R de Wit, W L J van Putten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Paclitaxel (Taxol) induces cumulative mild neurotoxicityJ M van Gerven, J W Moll, M J van den Bent, et al.
Japanese Journal of Infectious Diseases|October 25, 2006
Intestinal microsporidiosis in diarrheal patients infected with human immunodeficiency virus-1 in Addis Ababa, EthiopiaTekola Endeshaw, Amha Kebede, Jaco J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.
Pageof 66